Author

Joyce A. Sutcliffe

Observed names: J A Sutcliffe, J Sutcliffe, J. A. SUTCLIFFE, J. A. Sutcliffe, J. Sutcliffe, J.A. Sutcliffe, JOYCE A. SUTCLIFFE, JOYCE SUTCLIFFE, Joyce A Sutcliffe, Joyce Sutcliffe, Sutcliffe, J.A.

Observed institutions: National Institutes of Health, Pfizer (United States), National Institute of Diabetes and Digestive and Kidney Diseases, Melinta Therapeutics (United States), NanoBio (United States), Pfizer (Japan), Tetraphase Pharmaceuticals (United States), Ludwig-Maximilians-Universität München

OpenAlex ID: A5072618412

Detection of erythromycin-resistant determinants by PCR

1996 · J Sutcliffe, T Grebe, et al. · Antimicrobial Agents and Chemotherapy · 997

Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants

1999 · Marilyn C. Roberts, Joyce Sutcliffe, et al. · Antimicrobial Agents and Chemotherapy · 883

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

1996 · J Sutcliffe, A Tait-Kamradt, et al. · Antimicrobial Agents and Chemotherapy · 619

mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae

1997 · A Tait-Kamradt, J Clancy, et al. · Antimicrobial Agents and Chemotherapy · 297

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

2016 · Joseph Solomkin, David Evans, et al. · JAMA Surgery · 282

Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage

2000 · A. Tait-Kamradt, T. Davies, et al. · Antimicrobial Agents and Chemotherapy · 280

Resistance to Macrolide Antibiotics in Public Health Pathogens

2016 · Corey Fyfe, Trudy H. Grossman, et al. · Cold Spring Harbor Perspectives in Medicine · 271

PDF

Two New Mechanisms of Macrolide Resistance in Clinical Strains of Streptococcus pneumoniae from Eastern Europe and North America

2000 · A. Tait-Kamradt, T. Davies, et al. · Antimicrobial Agents and Chemotherapy · 261

Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens

2013 · J. A. Sutcliffe, W. O'Brien, et al. · Antimicrobial Agents and Chemotherapy · 239

Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic

2012 · Trudy H. Grossman, Agata L. Starosta, et al. · Antimicrobial Agents and Chemotherapy · 162

Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection

1996 · J Bergeron, M Ammirati, et al. · Antimicrobial Agents and Chemotherapy · 158

Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides

1996 · L Wondrack, M Massa, et al. · Antimicrobial Agents and Chemotherapy · 142

Emerging Targets in Antibacterial and Antifungal Chemotherapy

1992 · Joyce A. Sutcliffe, Nafsika H. Georgopapadakou · Springer eBooks · 127

Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent

2011 · Xiao-Yi Xiao, Diana K. Hunt, et al. · Journal of Medicinal Chemistry · 125

Phase 2, Randomized, Double-Blind Study of the Efficacy and Safety of Two Dose Regimens of Eravacycline versus Ertapenem for Adult Community-Acquired Complicated Intra-Abdominal Infections

2013 · Joseph S. Solomkin, Mayakonda Krishnamurthy Ramesh, et al. · Antimicrobial Agents and Chemotherapy · 124

In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii

2017 · Harald Seifert, Danuta Stefanik, et al. · International Journal of Antimicrobial Agents · 108

A New Antibiotic CJ-17,665 from Aspergillus ochraceus.

2001 · YUTAKA SUGIE, HIDEO HIRAI, et al. · The Journal of Antibiotics · 103

PDF

Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems

1990 · T D Gootz, J F Barrett, et al. · Antimicrobial Agents and Chemotherapy · 94

Improving on nature: antibiotics that target the ribosome

2005 · Joyce A Sutcliffe · Current Opinion in Microbiology · 91

Antibiotics in development targeting protein synthesis

2011 · Joyce A. Sutcliffe · Annals of the New York Academy of Sciences · 89

Biochemical characteristics and physiological significance of major DNA topoisomerases

1989 · J A Sutcliffe, T D Gootz, et al. · Antimicrobial Agents and Chemotherapy · 84

In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014–2015

2017 · George G. Zhanel, Melanie R. Baxter, et al. · Diagnostic Microbiology and Infectious Disease · 75

Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance

2008 · Eugene Skripkin, Timothy S. McConnell, et al. · Antimicrobial Agents and Chemotherapy · 75

Macrolide Resistance from the Ribosome Perspective

2004 · F. Franceschi, Z. Kanyo, et al. · Current Drug Targets - Infectious Disorders · 74

Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy

2011 · Roger B. Clark, Diana K. Hunt, et al. · Journal of Medicinal Chemistry · 73

Works count: 91

Citation count: 7,103

H-index: 40

I10-index: 58